Send to

Choose Destination
See comment in PubMed Commons below
Schweiz Arch Tierheilkd. 2011 Aug;153(8):351-60. doi: 10.1024/0036-7281/a000221.

[New concepts in human oncology: is it possible to use them in veterinary medicine as well?].

[Article in German]

Author information

  • 1Animal Oncology and Imaging Center, H├╝nenberg/ZG.


In human oncology, novel targeted therapy focusing on monoclonal antibodies and tyrosine kinase inhibitors has become an attractive anticancer strategy. The introduction of antiangiogenetic drugs and metronomic chemotherapy has also increased the therapeutic arsenal. Chemotherapy still plays a key role in the treatment of many tumors affecting dogs and cats. However, novel anticancer strategies (including tyrosine kinase inhibitors and monoclonal antibodies, as well as antiangiogenetic treatments) are becoming relevant in veterinary medicine, too. The goal of this review is to describe new therapeutic strategies for cancer treatment in veterinary medicine, including less well-known chemotherapeutic drugs.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Gesellschaft Schweizer Tieraerztinnen und Tieraerzte
    Loading ...
    Support Center